From: Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
Condition of interest | Observed mitochondria-related changes in brain disease |
---|---|
Alzheimer ‘s disease | |
• Impaired balance of mitochondrial fission and fusion [8, 28,29,30,31] | |
• Increased mtDNA mutation [36] | |
• Abnormal function of mitochondrial import channels [37] | |
• Accumulation of APP/Aβ in mitochondrial import channels [37] | |
• Impaired Na+/Ca2+ exchanger (mitochondrial Ca2+ overload) [42,43,44] | |
Traumatic Brain Injury | • Decreased mitochondrial membrane potential [50] |
• Reduced oxidase complex activity [52] | |
• Imbalance of mitochondrial fusion and fission induced mitochondrial respiration dysfunction, increased ROS production, and release of apoptosis- related factors [53,54,55,56,57] | |
• Impaired mitopahgy [58] | |
Stroke | • Failure of membrane ion pump, cellular potassium efflux, sodium influx, and the depolarization of the membrane [59,60,61] |
• The dysregulation of mitochondrial Ca2+ homeostasis [62,63,64] | |
• Excessive mitochondrial superoxide production [67,68,69] | |
Depression | • Inhibition of mitochondrial OXPHOS activity [78] |
• Inhibition of complexes in the mitochondrial respiratory chain and the activity of Na+, K + -ATPase [81,82,83,84,85] | |
Parkinson’s disease | |
• Genetic mutation induced mitochondrial dysfunction [92,93,94,95] | |
• Inappropriate trafficking of damaged mitochondria [103] | |
• Compromised mitophagy [104] |